Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Edaravone Dexborneol in Addition to Standard of Care in Patients With Hypertensive Intracerebral Hemorrhage: a Randomized, Double-Blind, Placebo-Controlled Trial

NCT04714177 is registered in ClinicalTrials.gov with First Affiliated Hospital, Sun Yat-Sen University as lead sponsor.

NCT NCT04714177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04714177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Edaravone Dexborneol in Addition to Standard of Care in Patients With Hypertensive Intracerebral Hemorrhage: a Randomized, Double-Blind, Placebo-Controlled Trial
Lead sponsor
First Affiliated Hospital, Sun Yat-Sen University
Phase
Phase 2
Overall status
Unknown status
Start date
March 1, 2021
Completion date
September 1, 2023
Enrollment
390 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

intracerebral hemorrhage